A novel SCN9A mutation responsible for primary erythromelalgia and is resistant to the treatment of sodium channel blockers (Q34576217)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A novel SCN9A mutation responsible for primary erythromelalgia and is resistant to the treatment of sodium channel blockers |
scientific article |
Statements
1 reference
A novel SCN9A mutation responsible for primary erythromelalgia and is resistant to the treatment of sodium channel blockers (English)
1 reference
Min-Tzu Wu
1 reference
Po-Yuan Huang
1 reference
31 January 2013
1 reference
1 reference
8
1 reference
1
1 reference
e55212
1 reference
31 January 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference